III. Integration and Control
18. Endocrine Glands
Clinical Focus DiabetesMellitus
Diabetes mellitus results primarily from
inadequate secretion of insulin or the in-
ability of tissues to respond to insulin.
Insulin-dependentdiabetes mellitus (IDDM),
also called type I diabetesmellitus, affects
approximately3% of people with diabetes
mellitusand results from diminished insulin
secretion. Itdevelops as a result of autoim-
mune destruction of the pancreatic islets,
and symptoms appear after approximately
90% ofthe islets are destroyed. IDDM most
commonlydevelops in young people. Hered-
ity may play some role in the condition,
although initiation of pancreatic islet
destruction mayinvolve a viral infection of
the pancreas (see the SystemsPathology
essayp 631).
Noninsulin-dependentdiabetes melli-
tus (NIDDM), also called type II diabetes
mellitus,results from the inability of tissues
to respond to insulin. NIDDM usuallydevel-
ops in people older than 40–45 years of
age, although the age ofonset varies con-
siderably. A strong geneticcomponent ex-
ists in the disease, butits actual cause is
unknown. A peptide hormone called leptin
(see chapter 25) produced byfat cells has
been shown to decrease the response of
targettissues to insulin. It is possible that
over production of substances like this
could be responsible for NIDDM. In some
cases, abnormalreceptors for insulin or an-
tibodiesmay bind to and damage insulin re-
ceptors, or, in other cases, abnormalities
may occur in the mechanismsthat the in-
sulin receptorsactivate.
NIDDM is more common than IDDM.
Approximately97% of people who have di-
abetes mellitus have NIDDM. The reduced
number of functional receptorsfor insulin
make the uptake ofglucose by cells very
slow, which results in elevated blood glu-
cose levels after a meal. Obesity is com-
mon, although not universal, in patients
with NIDDM. Elevated blood glucose levels
cause fat cells to convert glucose to fat,
even though the rate atwhich adipose cells
take up glucose is impaired. Increased
blood glucose and increased urine produc-
tion lead to hyperosmolality of blood and
dehydration ofcells. The poor use of nutri-
ents and dehydration of cells leads to
lethargy, fatigue, and periodsof irritability.
The elevated blood glucose levels lead to
recurrent infections and prolonged wound
healing.
Patientswith NIDDM don’t suffer sud-
den, large increases in blood glucose and
severe tissue wasting because a slow rate
ofglucose uptake does occur, even though
the insulin receptorsare defective. In some
people with NIDDM, insulin production
eventually decreases because pancreatic
isletcells atrophy and IDDM develops. Ap-
proximately 25%–30% of patients with
NIDDM take insulin, 50% take oralmedica-
tion to increase insulin secretion and in-
crease the efficiencyof glucose utilization,
and the remainder control blood glucose
levelswith exercise and diet.
Glucose tolerance testsare used to di-
agnose diabetes mellitus. In general, the
test involves feeding the patient a large
amountof glucose after a period of fasting.
Blood samples are collected for a few
hours, and a sustained increase in blood
glucose levels strongly indicates that the
person issuffering from diabetes mellitus.
Too much insulin relative to the amount
of glucose ingested leadsto insulin shock.
The high levels of insulin cause targettis-
suesto take up glucose at a very high rate.
Asa result, blood glucose levels rapidly fall
to a low level. Because the nervoussystem
depends on glucose asits major source of
energy, neurons malfunction because ofa
lackof metabolic energy. The result is a se-
ries of nervous system responses thatin-
clude disorientation, confusion, and
convulsions. Taking too much insulin, too lit-
tle food intake after an injection ofinsulin, or
increased metabolism ofglucose due to ex-
cessexercise by a diabeticpatient can cause
insulin shock.
It appears that damage to blood ves-
selsand reduced nerve function can be re-
duced in diabetic patients suffering from
either IDDM or NIDDM bykeeping blood glu-
cose wellwithin normal levels at all times.
Doing so, however, requires increased at-
tention to diet, frequentblood glucose test-
ing, and increased chance ofsuffering from
low blood glucose levels, which leads to
symptomsof insulin shock. A strict diet and
routine exercise are often effective compo-
nents of a treatment strategy for diabetes
mellitus, and in manycases diet and exer-
cise are adequate to controlNIDDM.
Chapter 18 Endocrine Glands 623
clines dramatically, even though blood levels of these molecules
may increase to very high levels.The satiety center requires insulin
to take up glucose.In the absence of insulin, the satiety center can-
not detect the presence of glucose in the extracellular fluid even
when high levels are present.The result is an intense sensation of
hunger in spite ofhigh blood glucose levels.
Blood glucose levels can fall to very low levels when too
much insulin is secreted.When too much insulin is present, target
tissues rapidly take up glucose from the blood,causing blood levels
of glucose to decline to very low levels.Although the nervous sys-
tem,except for cells of the satiety center,is not a target tissue for in-
sulin,the nervous system depends primarily on blood glucose for a
nutrient source.Consequently, low blood glucose levels cause the
central nervous system to malfunction.
Glucagon primarily influences the liver,although it has some
effect on skeletal muscle and adipose tissue (see table 18.11).
Glucagon binds to membrane-bound receptors,activates G proteins,
and increases cAMP synthesis.In general, glucagon causes the break-
down ofglycogen and increased glucose synthesis in the liver. It also
increases the breakdown of fats. The amount of glucose released
from the liver into the blood increases dramatically after glucagon
secretion increases.Because g lucagon is secreted into the hepatic
portal circulation,which carries blood from the intestine and pan-
creas to the liver,it is delivered in a relatively high concentration to